BRK.B
25
3
D
35
2
VNO
49
2
APH
58
5
EMR
62
6
INTU
57
3
JBHT
48
2
TSCO
48
5
NOV
50
3
CTAS
42
2
MNST
52
6
PWR
66
3
MSFT
58
4
ZBH
71
3
JNPR
62
2
WU
16
4
IVZ
48
3
AIZ
66
3
NTRS
44
5
KLAC
59
3
BRK.B
25
3
D
35
2
VNO
49
2
APH
58
5
EMR
62
6
INTU
57
3
JBHT
48
2
TSCO
48
5
NOV
50
3
CTAS
42
2
MNST
52
6
PWR
66
3
MSFT
58
4
ZBH
71
3
JNPR
62
2
WU
16
4
IVZ
48
3
AIZ
66
3
NTRS
44
5
KLAC
59
3
Financhill
Back

WAVE Life Sciences 10K Form

Sell
37

WVE
WAVE Life Sciences

Last Price:
$13.45
Seasonality Move:
-4.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q WVE/WAVE Life Sciences Quarterly
2023-08-03 10Q WVE/WAVE Life Sciences Quarterly
2023-05-03 10Q WVE/WAVE Life Sciences Quarterly
2022-11-10 10Q WVE/WAVE Life Sciences Quarterly
2022-08-11 10Q WVE/WAVE Life Sciences Quarterly
2022-05-12 10Q WVE/WAVE Life Sciences Quarterly

Receive WVE News And Ratings

See the #1 stock for the next 7 days that we like better than WVE

WVE Financial Statistics

Sales & Book Value

Annual Sales: $113.3M
Cash Flow: $-46.9M
Price / Cash Flow: 0
Annual Sales: $0.95
Price / Book: 14.44

Profitability

EPS (TTM): -1.11000
Net Income (TTM): $-142.5M
Gross Margin: $0
Return on Equity: -437.99%
Return on Assets: -55.78%

WAVE Life Sciences Earnings Forecast

Key WAVE Life Sciences Financial Ratios

  • The Selling, General & Administrative Expenses for WVE have been equal to 45.27% of Gross Profit Margin.
  • The Research & Development expenses have been 114.74% of Revenue.
  • The Net Earning history of WVE is -50.76% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

WAVE Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: WVE
CUSIP: Y95308
Website: wavelifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.9
Quick Ratio: 1.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

WVE Technical Analysis vs Fundamental Analysis

Sell
37
WAVE Life Sciences (WVE) is a Sell

Is WAVE Life Sciences a Buy or a Sell?

  • WAVE Life Sciences stock is rated a Sell
    The current WAVE Life Sciences [WVE] share price is $13.41. The Score for WVE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.